These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1938698)

  • 1. Determination of Pseudomonas aeruginosa susceptibility to aminoglycosides using API and Autobac semi-automated systems.
    de Rautlin de la Roy Y; Grollier G; Agius G; Borion N
    J Antimicrob Chemother; 1991 Jun; 27(6):868-70. PubMed ID: 1938698
    [No Abstract]   [Full Text] [Related]  

  • 2. The cation problem and susceptibility testing.
    Lewis JF
    Am J Clin Pathol; 1981 Oct; 76(4):508-9. PubMed ID: 6794353
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequencies of variants resistant to different aminoglycosides in Pseudomonas aeruginosa.
    Nilsson L; Sörén L; Rådberg G
    J Antimicrob Chemother; 1987 Aug; 20(2):255-9. PubMed ID: 3117761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of combinations of aminoglycosides with betalactamine on Pseudomonas aeruginosa strains in vitro].
    Meitert E; Petrescu AM; Chiru M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):41-50. PubMed ID: 3090675
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of Pseudomonas aeruginosa strains isolated from hospitalized children.
    Patzer J; Walkiewicz R; Dzierzanowska D
    J Antimicrob Chemother; 1986 Jul; 18(1):45-9. PubMed ID: 3093444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudomonas aeruginosa and Escherichia coli: reliability of antibiotic resistance results obtained by manual tests and automated and semi-automated equipment].
    Moretti MV; Bianchi P; Grossholz G; Moretti A; Pasticci MB; Frongillo RF
    Nuovi Ann Ig Microbiol; 1985; 36(6):453-64. PubMed ID: 3939640
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism of susceptibility and resistance of Pseudomonas aeruginosa to aminoglycosides].
    Iyobe S
    Nihon Rinsho; 1991 Oct; 49(10):2249-53. PubMed ID: 1749079
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of Pseudomonas aeruginosa sensitivity to antibiotics and features of interpreting the results].
    Givental' NI
    Antibiot Med Biotekhnol; 1987 Sep; 32(9):674-83. PubMed ID: 3124726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aminoglycosides and nosocomial infections. Our clinical experience].
    Scarpa RM; Ambus G; Carluccio A; Campus G; Cossu FM; Cantone R; Migliari R; Usai M; Usai E
    Minerva Urol Nefrol; 1988; 40(3):155-61. PubMed ID: 3149037
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tricentric study of the sensitivity of Pseudomonas aeruginosa serotyping to beta-lactams and aminoglycosides].
    Vachée A; Scheftel JM; Husson MO; Izard D; Ross P; Monteil H
    Pathol Biol (Paris); 1997 May; 45(5):357-62. PubMed ID: 9296084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro behavior of Pseudomonas, Serratia and Acinetobacter towards tobramycin].
    Denis F
    Nouv Presse Med; 1974 Apr; 3(0):48-51. PubMed ID: 4209338
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.
    Lally RT; Woolfrey BF; Enright MA
    J Clin Microbiol; 1989 Nov; 27(11):2616-8. PubMed ID: 2509514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Pseudomonas aeruginosa to currently available antibiotics.
    Jooste PJ; van Rensburg LJ; van Rensburg AJ
    S Afr Med J; 1977 Dec; 52(26):1034. PubMed ID: 416501
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
    Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antimicrobial drug combinations against Pseudomonas aeruginosa: beta-lactams and aminoglycosides.
    Martinetto P; Malcangi A; Penna R
    G Ital Chemioter; 1988; 35(1-3):17-21. PubMed ID: 3151486
    [No Abstract]   [Full Text] [Related]  

  • 19. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from children.
    Patzer J; Dzierzanowska D
    J Antimicrob Chemother; 1991 Dec; 28(6):869-75. PubMed ID: 1816183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
    Anan N; Toba S; Ito A; Nakamura R; Tsuji M
    Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.